NCT07390383 2026-02-09A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]Nanjing Leads Biolabs Co.,LtdPhase 2 Not yet recruiting110 enrolled